Sparfloxacin resistance in clinical isolates of Streptococcus pneumoniae: involvement of multiple mutations in gyrA and parC genes
about
Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae: contributions of type II topoisomerase mutations and efflux to levels of resistance.Prevalence of gyrA, gyrB, parC, and parE mutations in clinical isolates of Streptococcus pneumoniae with decreased susceptibilities to different fluoroquinolones and originating from Worldwide Surveillance Studies during the 1997-1998 respiratory seIn vitro and in vivo antibacterial activities of L-084, a novel oral carbapenem, against causative organisms of respiratory tract infections.Longitudinal assessment of antipneumococcal susceptibility in the United States.Draft Genome Sequence of Extensively Drug-Resistant Acinetobacter baumannii Strain CUAB1 from a Patient in Hong Kong, ChinaDNA gyrase and topoisomerase IV mutations in clinical isolates of Ureaplasma spp. and Mycoplasma hominis resistant to fluoroquinolonesActivities of fluoroquinolones against Streptococcus pneumoniae type II topoisomerases purified as recombinant proteinsIn vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV.Activities of mutant prevention concentration-targeted moxifloxacin and levofloxacin against Streptococcus pneumoniae in an in vitro pharmacodynamic model.Fluoroquinolone resistance in Streptococcus pneumoniae: area under the concentration-time curve/MIC ratio and resistance development with gatifloxacin, gemifloxacin, levofloxacin, and moxifloxacin
P2860
Q33594174-33C1540B-45CC-4EB6-BDAB-5BED7D4AD4AFQ33978849-3CEB7C21-EEFC-427D-B65B-CA707213473BQ33981178-3EF668EE-94FF-40BA-AADF-BED38308256CQ34110932-51E41FA4-3802-44F5-B89F-BFAEFE790763Q35608243-BF935B1D-E931-4A7F-AD1D-BB2D0E292553Q36047665-A52633A7-67F8-481D-A432-EF8B50DAE82FQ39472105-983B1097-19CF-4618-BFB3-D5A301D4668AQ39652121-B649F7AF-3586-4F84-A6E5-701C2326CCA3Q39792565-C9D03AA8-F643-46F8-897D-D84A72545BD3Q42078632-A9CF70C6-9570-4C8E-80E6-1FA615652D40
P2860
Sparfloxacin resistance in clinical isolates of Streptococcus pneumoniae: involvement of multiple mutations in gyrA and parC genes
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Sparfloxacin resistance in cli ...... tations in gyrA and parC genes
@ast
Sparfloxacin resistance in cli ...... tations in gyrA and parC genes
@en
type
label
Sparfloxacin resistance in cli ...... tations in gyrA and parC genes
@ast
Sparfloxacin resistance in cli ...... tations in gyrA and parC genes
@en
prefLabel
Sparfloxacin resistance in cli ...... tations in gyrA and parC genes
@ast
Sparfloxacin resistance in cli ...... tations in gyrA and parC genes
@en
P2860
P1476
Sparfloxacin resistance in cli ...... tations in gyrA and parC genes
@en
P2860
P304
P407
P577
1998-09-01T00:00:00Z